Although water produced by reverse osmosis (RO) filtration has low bacterial growth potential (BGP), post-treatment of RO permeate, which is necessary prior to distribution and human consumption, needs to be examined because of the potential re-introduction of nutrients/contaminants. In this study, drinking water produced from anaerobic groundwater by RO and post-treatment (ion exchange, calcite contactors, and aeration) was compared with that produced by conventional treatment comprising (dry) sand filtration, pellet softening, rapid sand filtration, activated carbon filtration, and UV disinfection. The multi-parametric assessment of biological stability included bacterial quantification, nutrient concentration and composition as well as bacterial community composition and diversity. Results showed that RO permeate remineralised in the laboratory has an extremely low BGP (50 ± 12 × 103 ICC/mL), which increased to 130 ± 10 × 103 ICC/mL after site post-treatment. Despite the negative impact of post-treatment, the BGP of the finished RO-treated water was >75% lower than that of conventionally treated water. Organic carbon limited bacterial growth in both RO-treated and conventionally treated waters. The increased BGP in RO-treated water was caused by the re-introduction of nutrients during post-treatment. Similarly, OTUs introduced during post-treatment, assigned to the phyla of Proteobacteria and Bacteroidetes (75–85%), were not present in the source groundwater. Conversely, conventionally treated water shared some OTUs with the source groundwater. It is clear that RO-based treatment achieved an extremely low BGP, which can be further improved by optimising post-treatment, such as using high purity calcite. The multi-parametric approach adopted in this study can offer insights into growth characteristics including limiting nutrients (why) and dominating genera growing (who), which is essential to manage microbiological water quality in water treatment and distribution systems.@en

The objectives of this study are to assess the performance of antiscalants in increasing the recovery (≥85%) of a reverse osmosis (RO) plant treating anaerobic groundwater (GW) in Kamerik (the Netherlands), and to identify scalants/foulant that may limit RO recovery. Five different commercially available antiscalants were compared on the basis of their manufacturer-recommended dose. Their ability to increase the recovery from 80% to a target of 85% was evaluated in pilot-scale measurements with anaerobic GW and in once-through lab-scale RO tests with synthetic (artificial) feedwater. A membrane autopsy was performed on the tail element(s) with decreased permeability. X-ray photoelectron spectroscopy (XPS) analysis indicated that calcium phosphate was the primary scalant causing permeability decline at 85% recovery and limiting RO recovery. The addition of antiscalant had no positive effect on RO operation and scaling prevention, since at 85% recovery, permeability of the last stage decreased with all five antiscalants, while no decrease in permeability was observed without the addition of antiscalant at 80% recovery. In addition, in lab-scale RO tests executed with synthetic feed water containing identical calcium and phosphate concentrations as the anaerobic GW, calcium phosphate scaling occurred both with and without antiscalant at 85% recovery, while at 80% recovery without antiscalant, calcium phosphate did not precipitate in the RO element. In brief, calcium phosphate appeared to be the main scalant limiting RO recovery, and antiscalants were unable to prevent calcium phosphate scaling or to achieve a recovery of 85% or higher.@en

Antiscalants are well known to prevent the precipitation of carbonate and sulphate scales of calcium in reverse osmosis (RO) applications, but according to literature their inhibitory ability against calcium phosphate is not clear. The objective of this study was to investigate if antiscalants, without acid addition, can prevent calcium phosphate scaling in RO systems. Eight calcium phosphate antiscalants from different manufacturers spanning a range of concentrations were tested in batch (in glass reactors) experiments to inhibit the formation of calcium phosphate in synthetic concentrate corresponding to 85% recovery (Ca2+ = 765 mg/L, PO43− = 13–15 mg/L and pH = 7.6) of a groundwater RO in the Netherlands. Additionally, once-through lab-scale RO tests were conducted where an RO element was fed with synthetic concentrate and the performance of antiscalants was evaluated from the rate of flux-decline in the RO element. Without antiscalant addition, a substantial flux-decline was observed due to the deposition of amorphous calcium phosphate (ACP) on the RO membrane. The tested antiscalants were unable to inhibit the formation of ACP and were incapable of preventing the deposition of the formed ACP particles, since with each antiscalant, the flux of the RO element decreased at least 15% in a 3-h period. Briefly, the available antiscalants, tested in this study, did not provide acceptable inhibition of calcium phosphate scaling in RO applications.@en

The potential of membrane scaling control by a real-time optimization algorithm was investigated. The effect of antiscalant dosing was evaluated from the induction time measured in glass batch-reactors, and from the operational performance of a lab-scale reverse osmosis (RO) unit and two pilot-scale RO units. Step changes in the antiscalant dosing demonstrated that the accumulation of scaling is ‘paused’ during periods when the optimum dose is applied. This is paramount for the application of a dynamic dosing strategy that may briefly underdose, while searching for the optimum dose. It was found that antiscalant underdose and overdose were both detrimental to RO operation since underdose resulted in membrane scaling, while overdose led to membrane fouling due to calcium-antiscalant deposits. The dosing algorithm was used to minimize antiscalant consumption in two pilot RO units. The algorithm was able to lower the antiscalant doses to 0.2 mg/L and 0.6 mg/L, while the supplier's recommended antiscalant doses were 2.0 mg/L and 4.5 mg/L, respectively. As a result, the algorithm could reduce antiscalant consumption by up to 85–90% for the plants mentioned.@en

The bacterial growth potential (BGP) of drinking water is widely assessed either by flow cytometric intact cell count (BGPICC) or adenosine triphosphate (BGPATP) based methods. Combining BGPICC and BGPATP measurements has been previously applied for various types of drinking water having high to low growth potential. However, this has not been applied for water with ultra-low nutrient content, such as remineralised RO permeate. To conduct a sound comparison, conventionally treated drinking water was included in this study, which was also used as an inoculum source. BGPICC, BGPATP, intact cell-yield (YICC), and ATP-yield (YATP) were determined for conventionally treated drinking water (Tap-water) and remineralised RO permeate (RO-water). In addition, both BGPICC and BGPATP methods were used to identify the growth-limiting nutrient in each water type. The results showed that the BGPICC ratio between Tap-water/RO-water was ∼7.5, whereas the BGPATP ratio was only ∼4.5. Moreover, the YICC ratio between Tap-water/RO-water was ∼2 (9.8 ± 0.6 × 106 vs. 4.6 ± 0.8 × 106 cells/µg-C), whereas the YATP ratio was ∼1 (0.39 ± 0.12 vs. 0.42 ± 0.06 ng ATP/µg-C), resulting in a consistently higher ATP per cell in RO-water than that of Tap-water. Both BGPICC and BGPATP methods revealed that carbon was the growth-limiting nutrient in the two types of water. However, with the addition of extra carbon, phosphate limitation was detected only with the BGPICC method, whereas BGPATP was not affected, suggesting that a combination of carbon and phosphate is essential for biomass synthesis, whereas carbon is probably utilised for cellular activities other than cell synthesis when phosphate is limited. It was estimated that the intact cell-yield growing on phosphate would be 0.70 ± 0.05 × 109 cells/µg PO4-P.@en